首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤血管生成抑制剂的作用机制研究进展
引用本文:Xiao D,Ding J. 肿瘤血管生成抑制剂的作用机制研究进展[J]. 生理科学进展, 1999, 30(3): 219-223
作者姓名:Xiao D  Ding J
作者单位:中国科学院上海药物研究所!上海200031
摘    要:肿瘤血管生成抑制剂批能破坏或抑制血管生成,有效地阻止肿瘤生长和转移的药物,可分为特异性和非特异性两大类。其作用机制主要有:(1)调控血管形成生长因子;(2)抑制基底膜降解;(3)影响信号转导通路;(4)调控细胞生长周期;(5)调控肿瘤机关基因。本文对其作用机制的进展作一综述。

关 键 词:肿瘤 血管生成抑制剂 作用机制

Advances in the study of mechanisms of the tumor angiogenesis inhibitors
Xiao D,Ding J. Advances in the study of mechanisms of the tumor angiogenesis inhibitors[J]. Progress in Physiological Sciences, 1999, 30(3): 219-223
Authors:Xiao D  Ding J
Affiliation:Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031.
Abstract:Tumor angiogenesis inhibitor is the drugs which can destroy or inhibit neovascularization, and block the growth and metastasis of cancer. For clinical applications it may be useful to divide the antiangiogenic drugs into two categories: class 1(specific inhibitors) and class 2 (non specific inhibitors).This review intends to provide the recent progress of the mechanisms of antiangiogenic drugs (1) Regulation of angiogenesis growth factors; (2) Inhibition of basement membrane degradation; (3) Mediating signal transduction pathway; (4) Effect of cell cycle; (5) Regulation of tumor related gene.
Keywords:Tumor  Angiogenesis inhibitor  
本文献已被 CNKI 维普 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号